Jasper Therapeutics director reports share holdings
Patrick J. Crutcher, a director of Jasper Therapeutics, Inc., directly holds 518,331.0000 shares of Voting Common Stock and Non-Voting Convertible Preferred Stock convertible into 463,452.0000 shares of Voting Common Stock.
Rhea-AI Filing Summary
Patrick J. Crutcher, a director of Jasper Therapeutics, Inc., directly holds 518,331.0000 shares of Voting Common Stock and Non-Voting Convertible Preferred Stock convertible into 463,452.0000 shares of Voting Common Stock. Each preferred share converts into 61 common shares after stockholder approval, subject to a 4.9%-19.9% beneficial ownership cap, and the preferred stock has no expiration date.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Crutcher Patrick J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Non-Voting Convertible Preferred Stock F1 | -- | -- | -- |
| holding | Voting Common Stock | -- | -- | -- |
Holdings After Transaction:
Non-Voting Convertible Preferred Stock — 463,452 contracts (Direct);
Voting Common Stock — 518,331 shares (Direct)
Footnotes (1)
- F1. On the third business day following the receipt of stockholder approval of the conversion of the preferred stock, each share of preferred stock shall automatically convert into 61 shares of the Issuer's voting common stock ("Voting Common Stock"), subject to certain limitations, including that a holder of Preferred Stock is prohibited from converting shares of preferred stock into shares of Voting Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than a specified percentage (to be established by the holder between 4.9% and 19.9%) of the total number of shares of Voting Common Stock issued and outstanding immediately after giving effect to such conversion. The preferred stock has no expiration date.
Key Figures
Voting Common Stock held: 518331.0000 shares
Underlying shares from preferred: 463452.0000 shares
Conversion ratio: 61 shares
+1 more
4 metrics
Voting Common Stock held
518331.0000 shares
Directly held by director Patrick J. Crutcher following the reported holdings
Underlying shares from preferred
463452.0000 shares
Voting Common Stock underlying Non-Voting Convertible Preferred Stock held directly
Conversion ratio
61 shares
Each preferred share converts into 61 shares of Voting Common Stock after stockholder approval
Beneficial ownership cap range
4.9%-19.9%
Holder-set limit on beneficial ownership of Voting Common Stock after conversion
Key Terms
Non-Voting Convertible Preferred Stock, Voting Common Stock, beneficially own, stockholder approval
4 terms
Non-Voting Convertible Preferred Stock financial
"security title is "Non-Voting Convertible Preferred Stock" convertible into Voting Common Stock"
A non-voting convertible preferred stock is a share that normally pays a fixed dividend and takes priority over common stock for payouts, but does not grant the holder the right to vote on corporate matters. It can be exchanged later for a set number of common shares, offering the potential to participate in price gains without immediate control—like holding a high-yield loan that can be turned into equity, which matters to investors weighing steady income, upside potential, and possible dilution of ownership.
Voting Common Stock financial
"each share of preferred stock shall automatically convert into 61 shares of the Issuer's voting common stock"
beneficially own financial
"holder ... would beneficially own more than a specified percentage of the total number of shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
stockholder approval regulatory
"following the receipt of stockholder approval of the conversion of the preferred stock"
Stockholder approval is formal consent given by a company’s shareholders, usually through a vote at a meeting or by proxy, for major actions such as mergers, asset sales, changes to corporate structure, or amendments to governance rules. Investors pay attention because the vote can enable or block steps that materially change a company’s direction, ownership or value—like neighbors voting to allow a major renovation that would alter a building’s use and worth.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How does the Non-Voting Convertible Preferred Stock in JSPR convert to common stock?
Each share of Non-Voting Convertible Preferred Stock automatically converts into 61 shares of Voting Common Stock on the third business day after stockholder approval of the conversion. This automatic conversion is also subject to a specified beneficial ownership limitation range.
What is the beneficial ownership limit on JSPR preferred stock conversion?
Conversion is limited so the holder cannot beneficially own more than a specified percentage of Voting Common Stock, set between 4.9% and 19.9%. This cap applies immediately after giving effect to any preferred stock conversion into Voting Common Stock.
Does the Non-Voting Convertible Preferred Stock of JSPR have an expiration date?
The Non-Voting Convertible Preferred Stock has no expiration date. It remains outstanding until converted into Voting Common Stock under the specified terms, including stockholder approval and compliance with the beneficial ownership percentage limitation.
AI-generated analysis. How Rhea-AI works. Not financial advice.
